Tubio, Almera .

HRN: 20-67-13  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/09/2023
CEFUROXIME 1.5GM (VIAL)
08/10/2023
08/16/2023
IVT
1.5g
Q8hrs
Choledocholithiasis
Checking Final Appropriateness 
08/10/2023
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
08/10/2023
08/15/2023
IVT
500mg Vial
Prior To OR Q8hrs
Choledocholithiasis
Checking Final Appropriateness 
08/18/2023
CEFUROXIME 1.5GM (VIAL)
08/18/2023
08/25/2023
IV
1.5gms
Q8
Post Operative Antibiotic
Checking Final Appropriateness 
08/18/2023
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
08/18/2023
08/25/2023
IV
500mg
Q8
Intra-abdominal Infection
Checking Final Appropriateness 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: